Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Smaller Deals

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Sep 20, 2024 6:05pm

137 Views

Post# 36234091

RE:RE:RE:RE:RE:RE:Smaller Deals

AGREED...but the main problem seems to be that most of their cash from the PPs goes to pay salaries and little is left for real lab work which is badly needed.
Like live animal cancer implants to test different treatments. And toxicology tests even if not GLP. Just to state what dosage of Rutherrin is safe for injection..Which then extrapolates to human injections.. All this will be needed to gain credibility. It should already have been done.
My fear is what will happen if their PP doesnt raise enough for salaries..layoffs or big pay reductions..?

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3